Sophie Combe
Paris, France
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 9 publications
Use of Vonicog Alpha and Acquired von Willebrand Syndrome, a New Approach: A Case Report.
Journal: Hamostaseologie
Published: March 22, 2024
Pharmacodynamics of eftrenonacog-alfa (rFIX-Fc) in severe hemophilia B patients: A real-life study.
Journal: European journal of pharmacology
Published: August 03, 2020
Effectiveness and safety of hFVIII/VWF concentrate (Voncento®) in patients with inherited von Willebrand disease requiring surgical procedures: the OPALE multicentre observational study.
Journal: Blood transfusion = Trasfusione del sangue
Published: July 22, 2020
FVIII dosages in persons with haemophilia A treated with extended half-life products: From local biology to optimized patient management.
Journal: Haemophilia : the official journal of the World Federation of Hemophilia
Published: January 31, 2019
Neutralization of EP217609, a new dual-action FIIa/FXa anticoagulant, by its specific antidote avidin: a phase I study.
Journal: European journal of clinical pharmacology
Published: August 22, 2016
Rituximab as first-line therapy for acquired haemophilia A: a single-centre 10-year experience.
Journal: Haemophilia : the official journal of the World Federation of Hemophilia
Published: April 01, 2016
First in man study of EP217609, a new long-acting, neutralisable parenteral antithrombotic with a dual mechanism of action.
Journal: European journal of clinical pharmacology
Published: March 08, 2016
New treatments for venous thromboembolic disease
Journal: Journal des maladies vasculaires
Published: December 20, 2011
Pharmacologic heterogeneity of new anticoagulants
Journal: Journal des maladies vasculaires
Published: December 20, 2011
Showing 1-9 of 9
Last Updated: 09/26/2026